Product logins

Find logins to all Clarivate products below.


: Cancer

Here you will find relevant articles and insight into all Clarivate related products and news.

Oncology, dermatology, hematology pace Q1 biopharma licensing Oncology, dermatology, hematology pace Q1 biopharma licensing
Blog June 11, 2019
Oncology, dermatology, hematology pace Q1 biopharma licensing
Business Development Cancer Cortellis Competitive Intelligence
Blog June 28, 2018
ASCO 2018: paradigm changers and emerging blockbusters
ASCO blockbuster Cancer
Blog April 25, 2018
ESMO session explores CDK inhibition and cell cycle modulation in cancer
Cancer CDK cell cycle modulator
Blog October 25, 2017
Accelerating – and maintaining – drug approvals in the U.S.
accelerated approval Advisory Committee Biologics
Blog July 13, 2017
Checkpoint inhibitors: a cutting edge in oncology
AstraZeneca atezolizumab avelumab
Blog June 12, 2017
NGS, maybe, sort of, sometimes clinic ready
ASCO Cancer Clinical Trials
Blog April 25, 2017
The 3 Rs of cancer research: rigor, reproducibility and robustness
Cancer Cortellis Oncology

Cancer

Oncology, dermatology, hematology pace Q1 biopharma licensing Oncology, dermatology, hematology pace Q1 biopharma licensing
Blog June 11, 2019
Oncology, dermatology, hematology pace Q1 biopharma licensing
Blog June 28, 2018
ASCO 2018: paradigm changers and emerging blockbusters
Blog April 25, 2018
ESMO session explores CDK inhibition and cell cycle modulation in cancer
Blog October 25, 2017
Accelerating – and maintaining – drug approvals in the U.S.
Blog July 13, 2017
Checkpoint inhibitors: a cutting edge in oncology
Blog June 12, 2017
NGS, maybe, sort of, sometimes clinic ready
Blog April 25, 2017
The 3 Rs of cancer research: rigor, reproducibility and robustness